Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alterity, Athenex, Aurigene Discovery, Beijing CC-Pharming, Bill & Melinda Gates Foundation, Bridge Biotherapeutics, China Grand, Clover, Curis, Ibio, Oncosec, Porton Pharma Solutions, Q Biomed, Recce.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bluegrass Vascular, Enzo Clinical Labs, Implant Direct, Lucid Diagnostics, Medicrea, Varian.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainstorm, Eli Lilly Canada, Fennec, Incyte, Ionis, Janssen, Logicbio, Lyndra, Marker, Novartis, Phasebio, Sirnaomics.